Primal Kaur

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

Andrew Menzies‐Gow, Jonathan Corren, Arnaud Bourdin et al. · New England Journal of Medicine · 2021 · 884 citations · Full text

Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study

Stanley Cohen, Mark C. Genovese, Ernest Choy et al. · Annals of the Rheumatic Diseases · 2017 · 182 citations · Full text

Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study

Kim Papp, H. Bachelez, Antonio Costanzo et al. · Journal of the American Academy of Dermatology · 2017 · 136 citations · Full text

NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma

Andrew Menzies‐Gow, Gene Colice, Janet M. Griffiths et al. · Respiratory Research · 2020 · 104 citations · Full text

Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients

Sophia Li, Primal Kaur, Virginia C. Chan et al. · Clinical Rheumatology · 2009 · 89 citations

Immunology, Pharmacotherapy, Retrospective Record Review +16